Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.97 EUR | +3.79% | +1.76% | -44.59% |
May. 03 | AB Science: upbeat after legal success | CF |
May. 03 | French Appeals Court Acquits AB Science CEO of Insider Trading Charges | MT |
Sales 2023 * | 930K 1M | Sales 2024 * | 990K 1.07M | Capitalization | 101M 108M |
---|---|---|---|---|---|
Net income 2023 * | -19M -20.45M | Net income 2024 * | -18M -19.37M | EV / Sales 2023 * | 108 x |
Net cash position 2023 * | - 0 | Net cash position 2024 * | - 0 | EV / Sales 2024 * | 102 x |
P/E ratio 2023 * |
-5.18
x | P/E ratio 2024 * |
-5.47
x | Employees | 89 |
Yield 2023 * |
-
| Yield 2024 * |
-
| Free-Float | 66.05% |
Latest transcript on AB Science
1 day | +3.79% | ||
1 week | +1.76% | ||
Current month | +2.71% | ||
1 month | -12.83% | ||
3 months | -36.96% | ||
6 months | -23.94% | ||
Current year | -44.59% |
Managers | Title | Age | Since |
---|---|---|---|
Alain Moussy
CEO | Chief Executive Officer | - | 01-07-10 |
Laurent Guy
DFI | Director of Finance/CFO | - | 01-12-31 |
Chief Tech/Sci/R&D Officer | - | 18-03-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Alain Moussy
CEO | Chief Executive Officer | - | 01-07-10 |
Patrick Moussy
BRD | Director/Board Member | - | 01-07-10 |
Director/Board Member | 62 | 21-06-26 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.00% | 10 M€ | -3.35% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-05-03 | 1.97 | +3.79% | 131,265 |
24-05-02 | 1.898 | -1.04% | 79,283 |
24-04-30 | 1.918 | -2.14% | 48,165 |
24-04-29 | 1.96 | +1.24% | 59,049 |
24-04-26 | 1.936 | +2.76% | 32,531 |
Real-time Euronext Paris, May 03, 2024 at 11:35 am EDT
More quotesEPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-44.59% | 108M | |
+5.48% | 71.19B | |
+12.55% | 9.3B | |
-13.75% | 5.01B | |
+42.38% | 4.47B | |
+4.51% | 3.96B | |
+21.10% | 2.44B | |
-19.05% | 2.41B | |
-28.72% | 2.23B | |
+11.13% | 2.02B |
- Stock Market
- Equities
- AB Stock